HOME Research Insight Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), and LiDCO Group plc (U.K.), dominate the Global Hemodynamic Monitoring Systems Market



Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), and LiDCO Group plc (U.K.), dominate the Global Hemodynamic Monitoring Systems Market


A number of key players are competing against each other to expand their existing customer base in the hemodynamic monitoring systems market. The top three players are expected to account for 60%-65% of the total hemodynamic monitoring systems market in 2016. These key players include Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), and LiDCO Group Plc (U.K.).

Edwards Lifesciences Corporation (U.S.) is the dominant player in the global hemodynamic monitoring systems market. The company is one of the leading providers of hemodynamic monitoring systems and disposables across the globe. The company develops and commercializes heart valve products and is one of the prominent manufacturers of heart valves and repair products for the replacement of defective heart valves. The company’s reporting business segments include Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Critical Care segment offers a wide range of hemodynamic systems. The company has succeeded in creating a strong foothold in the hemodynamic monitoring systems market owing to its diversified product portfolio, wide geographical reach and focus on acquisitions.

PULSION Medical Systems SE (Germany) is a prominent player of the global hemodynamic monitoring systems market. The company develops, manufactures, and supplies a broad range of hemodynamic monitoring systems and technologies. The company also produces and markets intravenous diagnostics and sterile disposable items used to monitor patients. The company offers the PiCCO platform used to monitor the hemodynamic state, the PulsioFlex platform used in perioperative medicine, and the PiCCO catheter that assists medical professionals to determine cardiovascular parameters. The company has gained a major share in the hemodynamic monitoring systems market on account of its widespread geographical presence and focus on R&D.

LiDCO Group plc (U.K.) is another leading player in the hemodynamic monitoring systems market. The company develops, manufactures, and supplies a broad range of hemodynamic monitors and software. Its systems are used by hospitals to treat high-risk patients in operating theaters and critical care units. The company focuses on agreements as one of its key growth strategies to enhance its global presence. In May 2016, LiDCO Group signed a distribution agreement with ICU Medical, Inc. (U.S.), a company which develops, manufactures, and sells medical technologies, to develop the LiDCO IM non-invasive hemodynamic monitoring system in the U.S. This agreement will expand presence of LiDCO Group in the U.S. With a diversified product portfolio, wide geographical reach, and focus on inorganic strategies, the company has succeeded in creating a strong foothold in the hemodynamic monitoring systems market.

The other players in the hemodynamic monitoring systems market are Cheetah Medical Inc. (Israel), Deltex Medical Group plc. (U.K.), Hemo Sapiens, Inc. (U.S.), ICU Medical, Inc. (U.S.), Osypka Medical GmbH (Germany), Schwarzer Cardiotek GmbH (Germany), and Tensys Medical, Inc. (U.S.).

Related Reports:

Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports